CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway - Wikidata - wikimedia - TriplyDB

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

http://www.wikidata.org/entity/Q36003309

about

Therapies targeting cancer stem cells: Current trends and future challenges A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma Slit/Robo pathway: a promising therapeutic target for cancer Development of a unique small molecule modulator of CXCR4 Mobilization of endogenous bone marrow derived endothelial progenitor cells and therapeutic potential of parathyroid hormone after ischemic stroke in mice Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans HIV tropism and decreased risk of breast cancer Extracellular ubiquitin increases expression of angiogenic molecules and stimulates angiogenesis in cardiac microvascular endothelial cells.Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo.Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation Chemokines and angiogenesis in rheumatoid arthritis.Vascular Robo4 restricts proangiogenic VEGF signaling in breast The role of chemoattractant receptors in shaping the tumor microenvironment.Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells.Chemokines and chemokine receptors in arthritis.Angiogenesis and its targeting in rheumatoid arthritis CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy.Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression.Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway.Phytochemistry and medicinal properties of Phaleria macrocarpa (Scheff.) Boerl. extracts.Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1.Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis.Seminal Levels of Pro-inflammatory (CXCL1, CXCL9, CXCL10) and Homeostatic (CXCL12) Chemokines in Men With Asymptomatic Chlamydia trachomatis Infection.Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.Co-treatment with therapeutic neural stem cells expressing carboxyl esterase and CPT-11 inhibit growth of primary and metastatic lung cancers in mice.Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization.Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells.The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.Inhibited experimental corneal neovascularization by neutralizing anti-SDF-1α antibody Attenuation of cartilage pathogenesis in post-traumatic osteoarthritis (PTOA) in mice by blocking the stromal derived factor 1 receptor (CXCR4) with the specific inhibitor, AMD3100 miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.CXCR4 gene transfer prevents pressure overload induced heart failure

P2860

Q26777880-F817A079-8622-4136-8E68-2549903AC8B5 Q26800288-E46B1DCD-84DD-4C6B-91F2-5DF45D793565 Q27026113-C3F3CD6A-BE20-4E59-8418-220F85BD4A35 Q27305638-4CCA3B9B-6D8F-457E-AE1E-29269DB89394 Q27324791-D0A06097-F10F-4508-A35B-C19FC67BF700 Q28083668-8DAC82B7-FC78-47D3-B592-41E191E697F8 Q28388722-EBC47757-66FE-4239-8070-BECD90B59AF3 Q28567974-92CB7324-E1A5-4259-AF1D-F399E92E17F6 Q28744167-D8C8683F-53EF-45D6-9096-79DCD8BF8E00 Q33656526-397AB71B-90C5-4829-B4C0-845656C4D478 Q33709960-7F4FE54B-D6C0-4513-8406-84E0037EC75C Q33778134-2BB64745-A759-44A1-9381-ACE5AE605AC1 Q33891809-5D61FA3D-F476-451E-BD25-342F375CBE61 Q33907157-FD3ABF0D-556B-47C7-8C63-CD59E1331EB7 Q33907274-7A461165-E019-4F29-BA0C-C8E4931C92FF Q33909030-23EC7897-0D1E-463B-8011-EDCC7BCA33B7 Q33934735-6DAC896D-92D5-4114-B4C7-8488E463689B Q33993124-61D2AFB7-68EA-4B98-A85B-E49305FD0DBB Q34009778-7FA43894-A2CF-4151-9CB5-9E7FB028B2C6 Q34051768-73678E9C-D292-473B-B825-10B3AE0085D8 Q34051950-242364E7-DE16-428F-8DDA-4D0830D5FEA3 Q34069720-095446F7-6FF5-4584-BEA5-278C5060CAD4 Q34071950-B7014F4F-9ED1-4BE7-A6E4-652CDCD26F30 Q34362205-0C451472-1B52-4E21-A05E-1E3ABDB5C047 Q34414241-D505A9E8-A170-4AD0-92DA-9E204F4F9F02 Q34476278-6B70DC5B-893A-4026-AE9A-0F164CDEB8B1 Q34541713-42AEC2D4-F8B5-42FB-973C-04B19D98A44D Q34901360-D3527B55-9840-4580-A34B-5D830B25A3D6 Q35083529-E3E3CB18-7AD3-40C0-A03A-F36780331475 Q35088560-2F1D8BC0-EC8E-4CBE-8B46-23FCE18BA4A5 Q35105027-D5202FDD-5313-4E9C-A3EA-E26EFD76FA81 Q35118166-84AC8FFC-E7D1-435C-8A2A-F6D6D51EED07 Q35149583-00CA9A12-E199-42D5-AD7F-06D32EE8D775 Q35166644-4155189F-EAA8-4079-B27B-69B4B15F0849 Q35828537-1F28A6EB-D342-49EE-83DC-1C98C20E0D6C Q35858991-15D439E1-D344-4581-9C84-62AAD2137BE5 Q35924203-243F6804-33D8-4F0C-A2BC-B8E0938FB219 Q36019622-1CDCB56F-CF29-4D6F-B25A-C1E1773B52B3 Q36068725-16C8F9E8-5FDA-4F42-8FF7-B2B9EDF9E186 Q36132472-31779F02-C3F5-4E95-B4E9-2617D05B68E7

P2860

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

http://www.wikidata.org/entity/Q36003309

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

@ast

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

@en

type

label

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

@ast

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

@en

prefLabel

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

@ast

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

@en

P1433

Q36003309-621692E2-A4CD-473C-B514-50657366BC61

P1476

Q36003309-FA904F33-DED5-4C5B-BC86-32847E415BB6

P2093

Q36003309-00DEE6B4-3FE1-4CDB-8D4E-9041D87DC7E9

Q36003309-08F3B1FD-5E26-4F00-83A0-8592E507AF76

Q36003309-0F10D4A2-7C08-427D-A1A9-7066C9210519

Q36003309-72188A03-F3DD-4966-892F-2C82FDEA1437

Q36003309-7299C01B-11B2-4645-A24B-88F0D07D18D1

Q36003309-A2AE9DBD-7DF8-4565-A128-0F2F8F30F3B4

Q36003309-C697C8E3-83FF-4F1B-9AED-85ECA765C598

P2860

Q36003309-08CD0BEB-6D56-49C7-AD2E-D75B37C7CF66

Q36003309-0D949BC7-9519-4CE9-90BA-35E3DA325AEF

Q36003309-2B66E5BE-F060-4F64-A40A-118008F95B9E

Q36003309-39B1A454-4A4E-4219-A8CD-799798620019

Q36003309-54A70D47-F61E-45A4-B480-A1A135E8DF49

Q36003309-5A820480-891A-4712-81C2-88373BA35C66

Q36003309-5CD32240-6388-4873-BE84-C3F952B669A2

Q36003309-5DE801BF-F8E2-4889-B8DF-050F80EEEDFF

Q36003309-69B104B6-CF11-4B7B-9172-0BBD7B924623

Q36003309-70D35B52-586C-4361-B235-84992949C65B

P304

Q36003309-B21A046F-727D-4EA3-8B25-E5954FA5E664

P31

Q36003309-4895E45E-9B72-4E42-B9A5-A6D88B0C4C25

P356

Q36003309-BA8F0849-FA09-4191-9B0B-E8A8A6965330

P407

Q36003309-263FFAEA-769C-4D23-838C-6B81ACA94CE3

P433

Q36003309-2D4E374C-0AA8-488B-B52F-74ED62A2C63F

P478

Q36003309-A6A9A07B-5C4B-407A-98FD-9B09BCB58864

P577

Q36003309-C7F19E82-BE8F-4204-BE78-29A4DA796DC6

P5875

Q36003309-817BF8A4-4C34-4282-AF60-04680836A2FF

P698

Q36003309-83A78AEC-241B-4A71-9EA7-F964460F8413

P932

Q36003309-71B24AA5-9F84-4B9F-AAA2-00F413647F83

P356

J.BBRC.2007.05.182

P1433

Biochemical and Biophysical Research Communications

P1476

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

@en

P2093

Hyunsuk Shim

http://www.w3.org/2001/XMLSchema#string

Joann Brooks

http://www.w3.org/2001/XMLSchema#string

Ke Liang

http://www.w3.org/2001/XMLSchema#string

Margaret Willard

http://www.w3.org/2001/XMLSchema#string

Seunghee Kang

http://www.w3.org/2001/XMLSchema#string

Younghyoun Yoon

http://www.w3.org/2001/XMLSchema#string

Zhongxing Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors

VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms

Tumorigenesis and the angiogenic switch

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

VEGF and the quest for tumour angiogenesis factors.

Silencing of CXCR4 blocks breast cancer metastasis

Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.

Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.

The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.

P304

716-722

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBRC.2007.05.182

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

359

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6276775

http://www.w3.org/2001/XMLSchema#string

P698

17559806

http://www.w3.org/2001/XMLSchema#string

P932

1986788

http://www.w3.org/2001/XMLSchema#string